Clinical Trial Update: A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 Diabetes [Phase 1]

View source ↗

Summary

This completed Phase 1 trial assesses the safety and preliminary effects of the experimental drug NNC0519 0130 in adults with obesity, with or without type 2 di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• NNC0519-0130

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2, Obesity | Phase 1 | Status: COMPLETED